High-throughput screening (HTS) enables rapid discovery but introduces assay, automation, and data challenges. This article ...

Real-time index price for PHLX Euro FX (XDE), along with buy or sell indicators, analysis, charts, historical performance, ...

HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat autoimmune ...

Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~~ Progressing AMT-130 ...

Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve vector quality, and low batch variability. San Sebastián, Spain, May ...

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion ...

Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“ Lithium Americas ” or the “ Company ”) announced that it has filed its Quarterly Report on Form 10-Q, which includes the Company’s unaudited condensed ...

Following the rise in Mpox cases, particularly in countries where the disease had not traditionally been observed, the World Health Organization (WHO) declared a Public Health Emergency of ...

A leading analyst provides his outlook for Boss Energy’s beaten down shares. The post Down 42% in a year, are Boss Energy shares now a bargain buy? appeared first on The Motley Fool Australia.

Following the rise in monkeypox (Mpox) cases, particularly in countries where the disease had not traditionally been observed, the World Health Organization (WHO) declared a Public Health Emergency of ...

SUEZ (Paris) and U.K.-based company Salinity Solutions announced the launch of the first Hybrid Batch Reverse Osmosis (HBRO) pilot dedicated to municipal ...

An Executive Order signed April 18, 2026 directs federal agencies to fast-track Food and Drug Administration (FDA) approval of and expand patient access to psychedelic drugs, such as psilocybin and ...